Table 1
Open in new tab

Genes of PCR array whose expression was up- or down-regulated in hMSCs by at least two-fold following exposure of the cells to plaque

Acc. No.SymbolDescriptionsRelative expressiona
Plaque/intimaPool/control
NM_001200BMP2Bone morphogenetic protein 22.019.3
NM_002986CCL11Chemokine (C-C motif) ligand 11; eotaxin4.03.4
NM_005408CCL13Chemokine (C-C motif) ligand 13; MCP-42.02.1
NM_002988CCL18Chemokine (C-C motif) ligand 18; PARC4.73.3
NM_000759CSF3Colony stimulating factor 3; G-CSF−2.3−3.7
NM_002089CXCL2Chemokine (C-X-C motif) ligand 2; GRO beta2.811.7
NM_000576IL1BInterleukin 1, beta3.912.6
NM_000589IL4Interleukin 41.84.9
NM_000600IL6Interleukin 61.33.6
NM_002188IL13Interleukin 135.53.4
NM_052872IL17FInterleukin 17F6.44.5
NM_006850IL24Interleukin 242.316.3
NM_145659IL27Interleukin 272.22.4
NM_005259MSTNMyostatin4.34.2
NM_003810TNFSF10Tumour necrosis factor (ligand) superfamily, member 10; TRAIL2.468.7
Acc. No.SymbolDescriptionsRelative expressiona
Plaque/intimaPool/control
NM_001200BMP2Bone morphogenetic protein 22.019.3
NM_002986CCL11Chemokine (C-C motif) ligand 11; eotaxin4.03.4
NM_005408CCL13Chemokine (C-C motif) ligand 13; MCP-42.02.1
NM_002988CCL18Chemokine (C-C motif) ligand 18; PARC4.73.3
NM_000759CSF3Colony stimulating factor 3; G-CSF−2.3−3.7
NM_002089CXCL2Chemokine (C-X-C motif) ligand 2; GRO beta2.811.7
NM_000576IL1BInterleukin 1, beta3.912.6
NM_000589IL4Interleukin 41.84.9
NM_000600IL6Interleukin 61.33.6
NM_002188IL13Interleukin 135.53.4
NM_052872IL17FInterleukin 17F6.44.5
NM_006850IL24Interleukin 242.316.3
NM_145659IL27Interleukin 272.22.4
NM_005259MSTNMyostatin4.34.2
NM_003810TNFSF10Tumour necrosis factor (ligand) superfamily, member 10; TRAIL2.468.7
a

Genes consistently regulated in both comparison groups: plaque relative to intima (set as 1) and pooled plaques relative to untreated control cells (set as 1).

Table 1
Open in new tab

Genes of PCR array whose expression was up- or down-regulated in hMSCs by at least two-fold following exposure of the cells to plaque

Acc. No.SymbolDescriptionsRelative expressiona
Plaque/intimaPool/control
NM_001200BMP2Bone morphogenetic protein 22.019.3
NM_002986CCL11Chemokine (C-C motif) ligand 11; eotaxin4.03.4
NM_005408CCL13Chemokine (C-C motif) ligand 13; MCP-42.02.1
NM_002988CCL18Chemokine (C-C motif) ligand 18; PARC4.73.3
NM_000759CSF3Colony stimulating factor 3; G-CSF−2.3−3.7
NM_002089CXCL2Chemokine (C-X-C motif) ligand 2; GRO beta2.811.7
NM_000576IL1BInterleukin 1, beta3.912.6
NM_000589IL4Interleukin 41.84.9
NM_000600IL6Interleukin 61.33.6
NM_002188IL13Interleukin 135.53.4
NM_052872IL17FInterleukin 17F6.44.5
NM_006850IL24Interleukin 242.316.3
NM_145659IL27Interleukin 272.22.4
NM_005259MSTNMyostatin4.34.2
NM_003810TNFSF10Tumour necrosis factor (ligand) superfamily, member 10; TRAIL2.468.7
Acc. No.SymbolDescriptionsRelative expressiona
Plaque/intimaPool/control
NM_001200BMP2Bone morphogenetic protein 22.019.3
NM_002986CCL11Chemokine (C-C motif) ligand 11; eotaxin4.03.4
NM_005408CCL13Chemokine (C-C motif) ligand 13; MCP-42.02.1
NM_002988CCL18Chemokine (C-C motif) ligand 18; PARC4.73.3
NM_000759CSF3Colony stimulating factor 3; G-CSF−2.3−3.7
NM_002089CXCL2Chemokine (C-X-C motif) ligand 2; GRO beta2.811.7
NM_000576IL1BInterleukin 1, beta3.912.6
NM_000589IL4Interleukin 41.84.9
NM_000600IL6Interleukin 61.33.6
NM_002188IL13Interleukin 135.53.4
NM_052872IL17FInterleukin 17F6.44.5
NM_006850IL24Interleukin 242.316.3
NM_145659IL27Interleukin 272.22.4
NM_005259MSTNMyostatin4.34.2
NM_003810TNFSF10Tumour necrosis factor (ligand) superfamily, member 10; TRAIL2.468.7
a

Genes consistently regulated in both comparison groups: plaque relative to intima (set as 1) and pooled plaques relative to untreated control cells (set as 1).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close